Cargando…

COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review

Although pediatric populations experienced lower COVID-19 severity and mortality than adults, the epidemiology of this disease continues to evolve. COVID-19 clinical manifestations in pediatrics commonly include fever and cough, but may differ from adults and by variant. Serious complications, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fergie, Jaime, Moran, Mary M., Cane, Alejandro, Pather, Shanti, Türeci, Ӧzlem, Srivastava, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781884/ https://www.ncbi.nlm.nih.gov/pubmed/36560448 http://dx.doi.org/10.3390/vaccines10122039

Ejemplares similares

Addressing COVID-19 vaccine hesitancy
por: Kassianos, George, et al.
Publicado: (2022)

Characterization of zolbetuximab in pancreatic cancer models
por: Türeci, Ӧzlem, et al.
Publicado: (2018)

Immunity to SARS-CoV-2: Lessons Learned
por: Fergie, Jaime, et al.
Publicado: (2021)

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
por: McLean, Gary, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults
por: Haranaka, Miwa, et al.
Publicado: (2021)

Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

Dangerous Liaisons: Caspase-11 and Reactive Oxygen Species Crosstalk in Pathogen Elimination
por: Roberts, JoAnn Simone, et al.
Publicado: (2015)

Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest
por: Moss, Paul, et al.
Publicado: (2022)

Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review
por: Marshall, Gary S., et al.
Publicado: (2022)

Septic Arthritis and Hemarthroses Caused by Haemophilus Influenzae Serotype A in Children
por: Samraj, Ravi S., et al.
Publicado: (2016)

Coronavirus Disease (COVID-19) and Pediatric Patients: A Review of Epidemiology, Symptomatology, Laboratory and Imaging Results to Guide the Development of a Management Algorithm
por: Hasan, Ali, et al.
Publicado: (2020)

Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
por: Simões, Eric A F, et al.
Publicado: (2023)

Murine Typhus in Children, South Texas
por: Purcell, Kevin, et al.
Publicado: (2007)

2721. US States’ Policies for Meningococcal Vaccination vs. Disease Epidemiology
por: Srivastava, Amit, et al.
Publicado: (2019)

COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
por: Di Fusco, Manuela, et al.
Publicado: (2022)

Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
por: Spinardi, Julia R., et al.
Publicado: (2023)

576. Burden of Pneumococcal Disease Due to Serotypes Covered by the 13-Valent and New Higher-Valent Pneumococcal Conjugate Vaccines in All Children and Children at Risk in the United States
por: Huang, Liping, et al.
Publicado: (2022)

Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US
por: McGrath, Leah J., et al.
Publicado: (2023)

Racing for a SARS‐CoV‐2 vaccine
por: Türeci, Özlem, et al.
Publicado: (2021)

Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid Review
por: Welch, Verna L., et al.
Publicado: (2023)

Myositis in a Child with Murine Typhus
por: Seshadri, Sheshashree, et al.
Publicado: (2014)

Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review
por: Napuri, Norka I., et al.
Publicado: (2022)

1021. Utility of Cell-Free DNA Sequencing in Diagnosing Murine typhus in Children
por: Medina-Carbonell, Victoria M, et al.
Publicado: (2021)

2638. Respiratory Syncitial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among 29–34 Weeks Gestational Age (wGA) Preterm Infants Before and After the 2014 American Academy of Pediatrics (AAP) Immunoprophylaxis Policy Change Using the Children’s Hospital Association’s Pediatric Health Information System (PHIS)
por: Fergie, Jaime, et al.
Publicado: (2019)

Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States
por: Pawaskar, Manjiri, et al.
Publicado: (2022)

Herd immunity and vaccination of children for COVID-19
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2020)

Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012)

High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature Review
por: Langer, Jakob, et al.
Publicado: (2023)

Epidemiological Determinants of Successful Vaccine Development
por: Nishiura, Hiroshi, et al.
Publicado: (2013)

Epidemiological characteristics, reinfection possibilities and vaccine development of SARS CoV2: A global review
por: Yadav, Ramakant, et al.
Publicado: (2021)

In Vitro Immune Organs-on-Chip for Drug Development: A Review
por: Shanti, Aya, et al.
Publicado: (2018)

Impact of the 2014 American Academy of Pediatrics Policy on RSV Hospitalization in Preterm Infants in the United States
por: Goldstein, Mitchell, et al.
Publicado: (2021)

Events Supposedly Attributable to Vaccination or Immunization after COVID-19 vaccines in children.
por: Lopes, Larissa Nathalia, et al.
Publicado: (2023)

Two Infants with Presumed Congenital Zika Syndrome, Brownsville, Texas, USA, 2016–2017
por: Howard, Ashley, et al.
Publicado: (2018)

Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity
por: Prashant, Chandravilas Keshvan, et al.
Publicado: (2014)

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer
por: Vormehr, Mathias, et al.
Publicado: (2020)

COVID‐19 disease and vaccination in pregnant and lactating women
por: Safadi, Marco A. P., et al.
Publicado: (2022)

Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis
por: Curcio, Daniel, et al.
Publicado: (2019)

Factors associated to acceptance and willingness to pay for COVID vaccine in Nepal
por: ACHARYA, DEVARAJ, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_35plnr1acp66js89pv8sqdtc88